Administration

LUXTURNA is a one-time gene therapy

The administration of LUXTURNA involves one subretinal injection per eye1

Graphic icon of a pill capsule

Corticosteroid regimen

Patients will follow a short-term corticosteroid regimen of oral prednisone (or the equivalent) before and after the administration of LUXTURNA to each eye1

Graphic icon of a syringe

Procedure

Under adequate anesthesia, a subretinal injection of LUXTURNA 1.5x1011 vector genomes (vg) in a total volume of 0.3 mL is performed on each eye separately using standard vitreoretinal techniques for subretinal surgery1,2

Administration is performed at an Ocular Gene Therapy Treatment Center by treatment center specialists on separate days within a close interval, but no fewer than 6 days apart1

LEARN MORE ABOUT TREATMENT CENTERS